NEW YORK, May 7-The research tool company MWG Biotech said last week that it will resell RNA synthesis products, services and technologies manufactured by Dharmacon Research, Inc.
The agreement covers markets worldwide, and is the first in an expected series of technical and marketing collaborations between the two companies.
This deal combines MWG Biotech's expertise in synthetic nucleic acid development and sale with Dharmacon's synthetic RNA products, allowing the two companies to expand their products and services, said MWG Biotech CEO Matthias Schonermark in a statement.
Dharmacon specializes in manufacturing synthetic RNA, used in structural studies and in RNA interference-based gene function research.
The Lafayette, Colo. company is privately owned.
MWG Biotech, based in Ebersberg, Germany, is a major manufacturer of synthetic DNA.